hexamethonium has been researched along with Acute Respiratory Distress Syndrome in 3 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogilvie, RI | 1 |
| Lezama, LA | 1 |
| Ni, H | 1 |
| Zhang, SJ | 1 |
| Zhang, RX | 1 |
| Shen, S | 1 |
| Yan, CH | 1 |
3 other studies available for hexamethonium and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
The death of a volunteer research subject: lessons to be learned.
Topics: Adult; Clinical Protocols; Fatal Outcome; Female; Ganglionic Blockers; Hexamethonium; Human Experime | 2001 |
Research guidelines: Hopkins deals with research volunteer death and aftermath.
Topics: Adult; Baltimore; Clinical Trials as Topic; Fatal Outcome; Female; Ganglionic Blockers; Hexamethoniu | 2002 |
[Changes in pulmonary arterial pressure during acute respiratory distress syndrome caused by injection of oleic acid in rabbits].
Topics: Animals; Antihypertensive Agents; Blood Pressure; Hexamethonium; Hexamethonium Compounds; Oleic Acid | 1986 |